Development Level

Tbio 5 | 10,625
Tdark 1 | 7,003

Disease

Cancer 4 | 2,346
psoriasis 3 | 6,685
Anemia 2 | 252
Atherosclerosis 2 | 275
Chagas disease 2 | 34
Heart disease 2 | 279
Kabuki syndrome 2 | 29
Kidney disease 2 | 397
Liver disease 2 | 219
Lung Neoplasms 2 | 171
Malaria 2 | 140
Neurodegenerative disease 2 | 383
diabetes mellitus 2 | 1,663
malignant mesothelioma 2 | 3,163
tuberculosis 2 | 1,563
APLASTIC ANEMIA, SUSCEPTIBILITY TO (finding) 1 | 3
Acquired immunodeficiency syndrome 1 | 164
Acute Promyelocytic Leukemia 1 | 32
Adult T-Cell Lymphoma/Leukemia 1 | 30
Antley-Bixler syndrome 1 | 15
Aortic Aneurysm, Abdominal 1 | 10
Aortic aneurysm 1 | 34
Aplastic anemia 1 | 19
Aplastic anemia, idiopathic 1 | 4
Appendicitis 1 | 18
Arthritis, Experimental 1 | 39
Arthritis, Infectious 1 | 2
Aspergillosis 1 | 23
Brain Diseases 1 | 22
Bronchiolitis Obliterans 1 | 5
Candidiasis 1 | 48
Cardiac arrest 1 | 26
Chlamydia 1 | 18
Chlamydia Infections 1 | 2
Chronic granulomatous disease 1 | 13
Combined oxidative phosphorylation deficiency 29 1 | 1
Common variable immunodeficiency 1 | 98
Congestive heart failure 1 | 36
Cryptococcosis 1 | 14
Diabetes Mellitus, Experimental 1 | 106
Diabetes Mellitus, Insulin-Dependent 1 | 77
Diarrhea 1 | 155
Drug-Induced Liver Injury 1 | 118
Encephalitis 1 | 54
Entamoebiasis 1 | 6
Eyelid Diseases 1 | 2
Fever 1 | 34
Glomerulonephritis 1 | 36
Glucosephosphate dehydrogenase deficiency 1 | 15
Graft-vs-Host Disease 1 | 5
HIV Infections 1 | 100
Heart failure 1 | 80
Hepatitis 1 | 61
Hepatitis C 1 | 90
Human immunodeficiency virus infectious disease 1 | 129
Human immunodeficiency virus type 1, susceptibility to 1 | 26
Hyperglycemia 1 | 120
Hyponatremia 1 | 6
Hypotension 1 | 53
Immune Complex Diseases 1 | 3
Impotence 1 | 45
Infection by Trichuris trichiura 1 | 2
Job Syndrome 1 | 3
Legionnaires' disease 1 | 20
Leishmaniasis, Cutaneous 1 | 8
Leishmaniasis, Visceral 1 | 13
Leprosy 1 | 77
Leukopenia 1 | 42
Lichen planus 1 | 17
Liver Cirrhosis, Experimental 1 | 108
Lymphatic system disease 1 | 14
Lymphoproliferative Disorders 1 | 3
Mammary Neoplasms 1 | 410
Melanoma 1 | 261
Meningitis 1 | 46
Myocardial Infarction 1 | 126
Nausea 1 | 9
Necrosis 1 | 51
Neoplasms, Experimental 1 | 33
Nerve Degeneration 1 | 73
Neural Tube Defects 1 | 31
Oral Submucous Fibrosis 1 | 18
Peripheral Vascular Diseases 1 | 2
Primary immunodeficiency disease 1 | 52
Pulmonary Embolism 1 | 45
Renal Insufficiency 1 | 10
Respiratory Syncytial Virus Infections 1 | 5
Respiratory Tract Diseases 1 | 6
Salmonella Infections, Animal 1 | 1
Sarcoma 1 | 49
Sepsis 1 | 21
Sleeping sickness 1 | 37
Stevens-Johnson syndrome 1 | 91
Tetanus 1 | 66
Toxoplasmosis 1 | 16
Tuberous sclerosis 1 | 18
Uveitis 1 | 103
Vomiting 1 | 9
non-inflammatory breast cancer 1 | 208
sarcoidosis 1 | 368

Tissue

Blood and immune system 6 | 17,995
Cardiovascular System 6 | 17,958
Digestive Tract 6 | 18,473
Endocrine System 6 | 18,512
Female tissues 6 | 18,647
Nervous System 6 | 18,561
Urinary Tract 6 | 18,444
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Respiratory system 5 | 17,484
Skin and soft tissues 5 | 18,115

Target Family

Non-IDG 4 | 11,969
Enzyme 1 | 4,146
Epigenetic 1 | 242

Grant Application

1R01HL109420-01A1 6 | 6
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Thioredoxin, mitochondrial TXN2 Tbio Non-IDG -2.03892 119.3 242
Interferon gamma IFNG Tbio Non-IDG -3.89133 5432.4 1711
Histone-lysine N-methyltransferase 2B KMT2B Tbio Epigenetic -1.88254 72.1 124
Actin-related protein T1 ACTRT1 Tdark Non-IDG 0.12 0.83 55
2,4-dienoyl-CoA reductase, mitochondrial DECR1 Tbio Enzyme -4.20993 15488.7 128
Disabled homolog 2-interacting protein DAB2IP Tbio Non-IDG -1.63307 53.6 59